SuperworthSI-BONE profit margin SIBN
Gross, operating and net profit as a share of revenue over the last twelve months, from 2018.
- Net margin, 12 months
- −6.9%
- Operating margin, 12 months
- −8.3%
- Net margin on a year earlier
- +6.0 pts
- Peer median
- 6.5%
Over the twelve months to Jun 30, 2026, SI-BONE kept −6.9% of its revenue as net profit, with an operating margin of −8.3% and a gross margin of 79.5%.
Five years earlier its net margin was −52.5%.
The median for 10 medical instruments and supplies stocks of a similar size is 6.5%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −9.4% | −11.1% | 79.6% |
| FY2024 | −18.5% | −21.1% | 79.0% |
| FY2023 | −31.2% | −33.8% | 78.8% |
| FY2022 | −57.6% | −56.0% | 85.2% |
| FY2021 | −62.8% | −57.3% | 88.4% |
| FY2020 | −59.5% | −52.6% | 87.9% |
| FY2019 | −57.1% | −53.5% | 89.9% |
| FY2018 | −31.5% | −21.6% | 91.3% |
| FY2017 | n/a | n/a | n/a |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −6.9% | +6.0 pts | −8.3% | |
| Q1 FY26 | −8.1% | +6.9 pts | −9.7% | |
| Q4 FY25 | −9.4% | +9.1 pts | −11.1% | |
| Q3 FY25 | −11.2% | +12.6 pts | −13.1% | |
| Q2 FY25 | −12.8% | +14.3 pts | −14.9% | |
| Q1 FY25 | −15.0% | +14.9 pts | −17.4% | |
| Q4 FY24 | −18.5% | +12.7 pts | −21.1% | |
| Q3 FY24 | −23.8% | +9.2 pts | −26.9% | |
| Q2 FY24 | −27.1% | +11.2 pts | −30.4% | |
| Q1 FY24 | −29.9% | +17.2 pts | −33.1% | |
| Q4 FY23 | −31.2% | +26.4 pts | −33.8% | |
| Q3 FY23 | −33.0% | +31.8 pts | −34.6% |
Against its peers
Companies in Medical - Instruments & Supplies nearest SI-BONE's size, closest first, today.
| Company | Profit margin |
|---|---|
| SIBNSI-BONE | −6.9% |
| IRMDIradimed | 26.7% |
| STAAStaar Surgical | 1.1% |
| BVSBioventus | 9.4% |
| CDRECadre | 5.3% |
| MOVMovado | 6.0% |
| EYENational Vision | 2.5% |
| MDXGMimedx | 1.8% |
| TCMDTactile Systems Technology | 7.1% |
| LMATLemaitre Vascular | 25.0% |
| INSPInspire Medical Systems | 15.0% |
| Peer median | 6.5% |
Where SI-BONE ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on SI-BONE
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.